606 related articles for article (PubMed ID: 35459868)
1. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
[TBL] [Abstract][Full Text] [Related]
2.
Emmanuel N; Li H; Chen J; Zhang Y
Oncotarget; 2022 Oct; 13():1136-1139. PubMed ID: 36264074
[TBL] [Abstract][Full Text] [Related]
3. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner.
Kim JW; Kim MJ; Han TH; Lee JY; Kim S; Kim H; Oh KJ; Kim WK; Han BS; Bae KH; Ban HS; Bae SH; Lee SC; Lee H; Lee EW
Cell Death Dis; 2023 Aug; 14(8):567. PubMed ID: 37633973
[TBL] [Abstract][Full Text] [Related]
4. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
[TBL] [Abstract][Full Text] [Related]
5. FSP1 is a glutathione-independent ferroptosis suppressor.
Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
[TBL] [Abstract][Full Text] [Related]
6. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation.
Müller F; Lim JKM; Bebber CM; Seidel E; Tishina S; Dahlhaus A; Stroh J; Beck J; Yapici FI; Nakayama K; Torres Fernández L; Brägelmann J; Leprivier G; von Karstedt S
Cell Death Differ; 2023 Feb; 30(2):442-456. PubMed ID: 36443441
[TBL] [Abstract][Full Text] [Related]
7. Ethanol extract of Eclipta prostrata induces multiple myeloma ferroptosis via Keap1/Nrf2/HO-1 axis.
Li W; Yin X; Fu H; Liu J; Weng Z; Mao Q; Zhu L; Fang L; Zhang Z; Ding B; Tong H
Phytomedicine; 2024 Jun; 128():155401. PubMed ID: 38507850
[TBL] [Abstract][Full Text] [Related]
8. Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer.
Lee J; Roh JL
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166788. PubMed ID: 37302427
[TBL] [Abstract][Full Text] [Related]
9.
Sitthideatphaiboon P; Galan-Cobo A; Negrao MV; Qu X; Poteete A; Zhang F; Liu DD; Lewis WE; Kemp HN; Lewis J; Rinsurongkawong W; Giri U; Lee JJ; Zhang J; Roth JA; Swisher S; Heymach JV
Clin Cancer Res; 2021 Mar; 27(6):1720-1733. PubMed ID: 33323404
[TBL] [Abstract][Full Text] [Related]
10. Activation of the P62-Keap1-NRF2 Pathway Protects against Ferroptosis in Radiation-Induced Lung Injury.
Li X; Chen J; Yuan S; Zhuang X; Qiao T
Oxid Med Cell Longev; 2022; 2022():8973509. PubMed ID: 35847598
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
12. Autophagy Inhibition Plays a Protective Role in Ferroptosis Induced by Alcohol via the p62-Keap1-Nrf2 Pathway.
Zhao Y; Lu J; Mao A; Zhang R; Guan S
J Agric Food Chem; 2021 Aug; 69(33):9671-9683. PubMed ID: 34388345
[TBL] [Abstract][Full Text] [Related]
13. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
14. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules.
Xavier da Silva TN; Schulte C; Alves AN; Maric HM; Friedmann Angeli JP
Cell Death Dis; 2023 Apr; 14(4):281. PubMed ID: 37080964
[TBL] [Abstract][Full Text] [Related]
16. Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1-Nrf2 protein-protein interaction from
Sun Y; He L; Wang W; Xie Z; Zhang X; Wang P; Wang L; Yan C; Liu Z; Zhao J; Cui Z; Wang Y; Tang L; Zhang Z
Food Funct; 2022 Jul; 13(14):7885-7900. PubMed ID: 35776077
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
18. DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma.
Chang K; Chen Y; Zhang X; Zhang W; Xu N; Zeng B; Wang Y; Feng T; Dai B; Xu F; Ye D; Wang C
Cancer Res; 2023 Dec; 83(23):3940-3955. PubMed ID: 37713596
[TBL] [Abstract][Full Text] [Related]
19. Phase separation of FSP1 promotes ferroptosis.
Nakamura T; Hipp C; Santos Dias Mourão A; Borggräfe J; Aldrovandi M; Henkelmann B; Wanninger J; Mishima E; Lytton E; Emler D; Proneth B; Sattler M; Conrad M
Nature; 2023 Jul; 619(7969):371-377. PubMed ID: 37380771
[TBL] [Abstract][Full Text] [Related]
20. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]